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BACKGROUND: Cardiovascular diseases (CVDs) and their risk factors need guideline- oriented treatment to provide the best 
benefit for patients. These guidelines include recommendations for regular checkups, realized by general medical practition-
ers. In addition, individuals with CVD or CVD risk factors tend to use complementary methods for their condition. There is 
limited information on the association between complementary healthcare utilization and the adherence to recommended 
conventional health care.
METHODS AND RESULTS: In this cross- sectional analysis of the nationally representative 2017 National Health Interview Survey 
(n=26 742; response rate 80.7%) we examined the prevalence of conventional and complementary healthcare utilization within 
the past 12 months in individuals with CVD and/or CVD risk factors and the interactions between the two categories of health 
care. Of all participants, 38.1% reported risk factors for CVD and 11.4% a CVD diagnosis (groups show an overlap). Overall 
prevalence of visits to conventional and complementary medicine providers and the use of mind–body medicine was high 
within the population analyzed. Individuals with CVD and/or CVD risk factors using complementary health care were as likely 
or more likely to consult general practitioners (CVD: adjusted odds ratio [aOR], 1.17; 95% CI, 0.93–1.47; CVD risk: aOR, 1.21; 
95% CI, 1.05–1.39) and medical specialists (CVD: aOR, 1.38; 95% CI, 1.17–1.64; CVD risk: aOR, 1.42; 95% CI, 1.28–1.58) than 
those not using complementary health care. Those using complementary health care were as likely to adhere to medical 
checkup as those not using complementary health care.
CONCLUSIONS: Complementary healthcare utilization use was not associated with a reduced adherence to conventional health 
care and recommended checkups. The potential positive association of complementary and conventional healthcare utiliza-
tion needs to be confirmed in further studies.
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Cardiovascular diseases (CVDs) comprise multiple disorders that affect the blood vessels and can lead to (sub)acute events such as stroke, ischemic 
heart disease, or congestive heart failure.1 Since 1990, 
CVD has been identified as the leading cause of death in 
both developed and nondeveloped countries. Within the 
past 3 decades, cardiovascular mortality has increased 
significantly2; in 2016, about every third death was caused 
by CVD, which amounts to an estimated 17.9 million peo-
ple worldwide.1 Thus, direct and indirect economic costs 
caused by CVD and associated risk factors contribute to 
the high burden inflicted on healthcare systems.3
CVDs are mainly associated with certain pre-
dominantly modifiable risk factors. Most importantly, 
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unhealthy eating habits leading to diabetes mellitus, 
obesity, hyperlipidemia, lack of physical exercise, 
smoking, alcohol consumption, arterial hyperten-
sion, etc, can increase the risk of developing an acute 
event.1,4 Further factors associated with CVD include 
hereditary reasons,5 psychosocial stress, and depres-
sion.1 Also, low socioeconomic status, as defined by 
living environment, educational level, employment 
status, etc, increases cardiovascular risk.6 Although 
changes in lifestyle habits could positively affect up to 
75% of the aforementioned CVD risk factors, disease 
prevalence has continued to increase1 according to the 
World Health Organization.7,8
It is important to establish optimal treatment 
supported by international guideline recommenda-
tions.9 This would improve the patient outcomes by 
reducing mortality and hospitalization rates.10 The 
American College of Cardiology and American Heart 
Association regularly present updated international 
guidelines. Among others, these include therapeu-
tic options, such as primary prevention via lifestyle 
changes and medical treatment options that offer pa-
tients the greatest benefit.8 Focusing on primary pre-
vention, periodic control of blood sugar, cholesterol, 
arterial blood pressure, and anamnesis by medical 
practitioners is recommended.8 To maintain treatment 
goals, including medication and lifestyle changes, an 
enhanced cooperation between the various medical 
practitioners, patients themselves, and social sur-
roundings can lead to the best results.11,12
Data from the National Health Interview Survey 
(NHIS) show that almost 40% of United States citi-
zens utilize complementary medicine approaches, 
and that medical conditions treated with such ap-
proaches include CVD risk factors such as high levels 
of cholesterol.13 Complementary medicine describes a 
combination of conventional health care and various 
therapies, such as yoga, mind–body medicine (MBM), 
traditional Chinese medicine, osteopathy, chiropractic, 
and many others.14 The idea of preventive and com-
plementary medicine involves an overlap, especially 
with regard to lifestyle modification.15 Although use of 
complementary medicine approaches with conven-
tional care appears beneficial in individuals with CVD 
or CVD risk factors,16–23 relying solely on complemen-
tary approaches could result in poorer outcome. More 
specifically, complementary medicine use may be as-
sociated with lower adherence to necessary medical 
treatments or checkups.24
We used a large US representative data source to 
analyze the prevalence of conventional and comple-
mentary healthcare utilization in adults with CVD and/
or CVD risk factors, and the associations between the 
2 categories of health care. Specifically, we analyzed 
whether conventional healthcare utilization rates differ 




We analyzed data from the 2017 NHIS. Data, methods 
used in the analysis, and materials used to conduct 
the research are available online to any researcher 
for purposes of reproducing the results or replicat-
ing the procedure (https://www.cdc.gov/nchs/nhis/
index.htm). Conducted annually by the National 
Center for Health Statistics (NCHS), the NHIS is rep-
resentative of the noninstitutionalized US population. 
In 2017, the survey included 32 617 households, and 
26 742 adults provided data (response rate 80.7%). 
Using population- based estimates, calculated using 
weights calibrated to the 2010 census population, 
the survey was representative for a weighted total 
CLINICAL PERSPECTIVE
What Is New?
• Earlier research showed that complementary 
medicine utilization is common among patients 
with cardiovascular disease (CVD) or CVD risk 
factors, although exact numbers vary.
•  It has not been analyzed whether complemen-
tary medicine utilization affects the general 
health behavior on conventional medicine of 
patients with CVD or CVD risk factors.
•  In our analysis of the 2017 National Health 
Interview Survey individuals with CVD or CVD 
risk factors consulting complementary medicine 
practitioners and/or using mind–body medicine 
were also more likely to consult general medical 
practitioners.
What Are the Clinical Implications?
•  Due to a higher adherence to conventional 
medicine and recommended checkups, com-
plementary medicine utilization can have a posi-
tive effect on conventional health behavior in 
patients with CVD or at risk of CVD.
•  The potential positive association of comple-
mentary and conventional healthcare utilization 
needs to be confirmed in further studies.
Nonstandard Abbreviations and Acronyms
CVD cardiovascular disease
MBM mind–body medicine
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of 246 657 271 US adults. More information on sur-
vey composition, sampling strategy, and administra-
tion of the NHIS is available from the US Centers for 
Disease Control and Prevention (http://www.cdc.gov/ 
nchs/nhis/about_nhis.htm; ftp://ftp.cdc.gov/pub/hea 
lth_stati stics/ nchs/datas et_docum entat ion/nhis/ 
2017/srvyd esc.pdf).
The research ethics review board of the NCHS ap-
proved the NHIS data collection protocol on June 12, 
2015 (Protocol #2015- 08). All participants provided in-
formed consent.
In this analysis, we used data from the NHIS Family 
File, NHIS Person File, and NHIS Sample Adult File. 
Specifically, we extracted sociodemographic data and 
clinical data, including data on CVD diagnoses and 
CVD risk factors, as well as on conventional and com-
plementary healthcare use.
For assessing CVD diagnoses, we analyzed self- 
report data on earlier diagnoses of coronary heart 
disease, myocardial infarction, angina pectoris, and 
unspecified heart conditions. We classified partici-
pants who reported at least 1 of these diagnoses as 
CVD patients. Further, we analyzed self- report data 
on cardiovascular risk factors, including hypertension, 
hypercholesterolemia, and diabetes mellitus or pre-
diabetes mellitus. We classified participants who re-
ported ≥1 of these risk factors as individuals with CVD 
risk factors; those who fell into this category but not 
into the CVD patient category were further classified 
as individuals with CVD risk factors but without a CVD 
diagnosis.
For healthcare utilization, we analyzed self- 
reported consultations with physicians (general 
practitioners and/or medical specialists) and with 
complementary medicine practitioners (chiroprac-
tors, naturopaths, practitioners of chelation therapy, 
practitioners of traditional medicine, and/or homeo-
paths) in the past 12 months. We also analyzed the 
total number of consultations with any healthcare 
practitioners in the past 12  months and classified 
them as none, 1 to 3, and ≥4 office visits. We finally 
analyzed preventive cardiology care use, including 
blood pressure, cholesterol, and fasting glucose as-
sessments, in the past 12 months, as well as MBM 
use, which included mantra meditation, mindfulness 
meditation, spiritual meditation, guided imagery, pro-
gressive relaxation, yoga, tai chi, and qi gong. We 
classified participants who had consulted at least 1 
complementary medicine practitioner and/or utilized 
MBM in the past 12 months as complementary med-
icine users.
Statistical Analysis
We calculated the prevalence of consultations 
with conventional and complementary medicine 
practitioners as well as preventive cardiology care 
and MBM utilization in the past 12 months. Prevalence 
was calculated separately for the general population, 
CVD patients, and individuals with CVD risk factors 
but no diagnosis of a CVD, using absolute weights. 
Thereby, every survey participant was representa-
tive for a mean of 9223.59 individuals of the general 
population.
We further analyzed associations between con-
ventional and complementary care by multiple logis-
tic regression analyses. Because absolute weights 
would inflate sample size in inferential tests, the rel-
ative weights were calculated by dividing the partic-
ipant’s individual weight by the mean weight across 
the survey participants. Thus, we preserved the orig-
inal sample size as well as the advantages of the 
NHIS complex sampling strategy. Specifically, we 
analyzed independent predictors of consultations 
with a general practitioner or medical specialist as 
well utilization of preventive cardiovascular care in 
the past 12 months. The main predictor of interest 
was use of complementary medicine in the past 
12  months. For each conventional practitioner and 
preventive care type, we conducted a separate re-
gression analysis controlling for the following po-
tential sociodemographic and clinical confounders: 
age (categories 18–29, 30–39, 40–49, 50–64, and 
≥65 years); ethnicity (non- Hispanic white, Hispanic, 
African American, Asian, other); region (West, 
Northeast, Midwest, South); marital status (not in 
relationship, in relationship); education (less than 
college, some college or more); employment (em-
ployed, unemployed); health insurance coverage 
(coverage, no coverage); noncardiovascular comor-
bidities, including: (1) previous diagnoses of stroke, 
emphysema, chronic obstructive disease, asthma, 
ulcer, epilepsy, hay fever, sinusitis, bronchitis, kidney 
disease, liver disease, and arthritis; (2) neck, back, 
facial pain, or headache in the past 3 months; and (3) 
head or chest cold, stomach problems, diarrhea, or 
vomiting in the past 2 weeks, and the CVD risk fac-
tors hypertension, hypercholesterinemia, and diabe-
tes mellitus/prediabetes mellitus (yes, no). Analyses 
of CVD patients also controlled for the specific type 
of CVD diagnoses, including coronary heart disease, 
myocardial infarction, angina pectoris, unspecified 
heart conditions, and stroke (previous diagnosis, no 
previous diagnosis). Only those potential confound-
ers associated with the respective dependent vari-
able with P≤0.10 on univariate analysis (chi- square 
test) were included in the regression analyses. We 
computed adjusted odds ratio with 95% CI and con-
sidered P≤0.05 to be statistically significant in the 
regression analysis. All statistical analyses were per-
formed using SPSS Statistics for Windows release 
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RESULTS
A weighted total of 93 943 190 (38.1%) participants re-
ported risk factors for CVD and 28 214 424 participants 
(11.4%) had received a CVD diagnosis, with a large 
overlap between the 2 groups. A total of 74 449 360 
(30.2%) participants reported CVD risk factors but no 
diagnosis of CVD. Demographics and clinical charac-
teristics of patients with CVD and/or risk factors for 
CVD are reported in Table 1.
Adults with CVD risk factors but without CVD diagno-
sis had a higher prevalence of consultation with general 
practitioners and medical specialists than the general 
population, and CVD patients had higher prevalence of 
consultations than the general population and individu-
als with CVD risk factors but no manifest CVD (Figure 1). 
The same was true for consultations with complementary 
medicine practitioners except for consultations with che-
lation therapy practitioners and homeopaths (Figure  1). 
Among individuals with CVD risk factors but no manifest 
CVD, 92.5% had consulted healthcare practitioners at least 
once in the past 12 months, and 49.5% had ≥4 office vis-
its. Among CVD patients, 92.6% had consulted healthcare 
practitioners at least once in the past 12 months, 60.4% 
had ≥4 office visits in the past 12  months. Prevalence 
of preventive cardiovascular care is shown in Figure 2.
In addition, 23.6% of the general population, 22.8% 
of CVD patients, and 21.1% of individuals with CVD risk 
factors, but no manifest CVD used MBM, with yoga 
and spiritual meditation being the most commonly 
used mind–body modalities (Figure 3).
Altogether, 31.2% of the general population, 31.8% 
of CVD patients, and 29.7% of individuals with CVD 
risk factors, but no manifest CVD had used any form of 
complementary medicine.
Conventional and complementary medicine use were 
associated with each other among CVD patients and 
even more pronounced in individuals with CVD risk fac-
tors but no manifest CVD. In the latter group, individuals 
using complementary medicine significantly more often 
also consulted general practitioners and medical spe-
cialists compared with those not using complementary 
medicine. Patients with manifest CVD using complemen-
tary medicine also more often consulted medical special-
ists (but not general practitioners) than patients not using 
complementary medicine (Table 2). More individuals using 
complementary medicine also attended blood pressure 
and fasting glucose checkups in the previous 12 months 
than those not using complementary medicine, but these 
differences did not reach statistical significance (Table 2).
DISCUSSION
In this study we have reported on the association of 
complementary medicine use and use of general and 
Table 1. Demographic and Clinical Characteristics of 





CVD Risk Factors 
(n=74 418 456)
Age, y
18 to 29 4 655 577 (16.5%) 11 868 557 (15.9%)
30 to 39 4 673 002 (16.6%) 11 285 140 (15.2%)
40 to 49 4 016 159 (14.2%) 11 286 622 (15.2%)
50 to 64 7 162 018 (25.4%) 19 723 779 (26.5%)
65 7 707 668 (27.3%) 20 254 358 (27.2%)
Sex
Male 14 854 519 (52.6%) 34 833 855 (46.8%)
Female 13 359 905 (47.4%) 39 584 601 (53.2%)
Ethnicity
Non- Hispanic white 20 349 434 (72.1%) 52 311 462 (70.3%)
Hispanic 3 145 412 (11.1%) 9 125 269 (12.3%)
Black 3 064 952 (10.9%) 7 937 718 (10.7%)
Asian 1 353 923 (4.8%) 4 034 139 (5.4%)
Other 300 703 (1.1%) 1 009 868 (1.4%)
Region
West 5 763 735 (20.4%) 17 383 022 (23.4%)
Northeast 5 114 419 (18.1%) 13 406 517 (18.0%)
Midwest 7 074 651 (25.1%) 15 050 514 (20.2%)
South 10 261 619 (36.4%) 28 578 403 (38.4%)
Employment
Not employed 18 088 329 (64.2%) 34 110 618 (45.8%)
Employed 10 106 002 (35.8%) 40 305 268 (54.2%)
Education
Less than college 14 854 519 (52.6%) 34 833 855 (46.8%)
Some college or 
more
13 359 905 (47.4%) 39 584 601 (53.2%)
Marital status
Not in a relationship 11 440 946 (40.6%) 26 864 436 (36.2%)
In a relationship 16 743 167 (59.4%) 47 416 355 (63.8%)
Health insurance
Yes 26 839 475 (95.1%) 69 360 825 (93.2%)





Myocardial infarction 7 583 582 (26.9%) …





Hypertension 14 351 327 (50.9%) 41 717 225 (56.1%)
Hypercholesterinemia 11,107,136 (39.4%) 37 082 840 (49.8%)
Diabetes mellitus/
prediabetes mellitus
9 589 248 (34.0%) 32 221 417 (43.3%)
Data expressed as weighted frequencies. CVD indicates cardiovascular 
disease.
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complementary health care among US citizens with CVD 
and/or CVD risk factors. Individuals with CVD or CVD risk 
factors who utilized complementary medicine health care 
were as likely, or even more likely, to consult general medi-
cal practitioners and specialists, and to adhere to neces-
sary checkups, compared with those who did not.
The general use of complementary health care 
in CVD as seen in our data is comparable with that 
seen in earlier studies. In 2012, a systematic review 
analyzed 27 studies—primarily data from the United 
States, Canada, and the United Kingdom. The results 
showed that use of complementary health care in CVD 
Figure 1. Twelve- month prevalence of consultations with conventional and complementary medicine practitioners in: (1) the 
general adult population; (2) adults with cardiovascular disease (CVD); or (3) adults with CVD risk factors but no manifest CVD.
Weighted frequencies were used.
Figure 2. Twelve- month prevalence of preventive cardiovascular care in: (1) the general adult population; (2) adults with 
cardiovascular disease (CVD); or (3) adults with CVD risk factors but no manifest CVD.
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is common, although variable. The general prevalence 
of conventional medicine use ranged from 4% to 61%, 
respectively, and from 19% to 64% when only studies 
with comprehensive definitions of conventional and al-
ternative medicine were included. Data among types 
of complementary healthcare utilization and reasons 
for it varied. Reasons mentioned included: belief of 
greater benefit vs. conventional therapy; treatment of 
adverse drug reactions to conventional medication; or 
treatment of a manifest CVD. In manifest heart failure, 
7% to 82% of patients utilized complementary medi-
cine to treat their condition.25 Furthermore, in 2007, the 
NHIS already showed that people with CVD or CVD 
risk factors were more likely to use complementary 
medicine than the general population.26
Although this is the first US nationally representa-
tive analysis to show a positive relationship between 
complementary and conventional healthcare utiliza-
tion in individuals with CVD or CVD risk factors, our 
findings are in line with earlier work from other coun-
tries. In 2013, Canaway et  al conducted a survey of 
2766 Australian patients with diabetes mellitus and/
or CVD. Participants were asked about their use of 
general health services and use of complementary 
Figure  3. Twelve- month prevalence of mind–body medicine use in: (1) the general adult population; (2) adults with 
cardiovascular disease (CVD); or (3) adults with CVD risk factors but no manifest CVD.
Weighted frequencies were used.
Table 2. Associations of Consultations With CM Providers and Conventional Healthcare Utilization in Adults With CVD or 
CVD Risk Factors But No Manifest CVD
CVD Patients Using CM Individuals With CVD Risk Factors Using CM
OR (95% CI)
Adjusted OR 
(95% CI) P Value OR (95% CI)
Adjusted OR (95% 
CI) P Value
Physician consultations past 12 months
General physician 
consultation
1.09 (0.88–1.34) 1.17 (0.93–1.47) 0.18 1.28 (1.13–1.47) 1.21 (1.05–1.39) <0.01
Medical specialist 
consultation
1.25 (1.07–1.46) 1.38 (1.17–1.64) <0.01 1.50 (1.36–1.66) 1.42 (1.28–1.58) <0.01
Preventive care past 12 months
Blood pressure check 1.04 (0.78–1.40) 1.13 (0.82–1.55) 0.47 1.12 (0.94–1.34) 1.10 (0.91–1.32) 0.33
Cholesterol check 0.79 (0.67–0.94) 0.98 (0.81–1.12) 0.87 0.89 (0.80–1.00) 0.96 (0.85–1.08) 0.51
Fasting glucose check 1.00 (0.85–1.17) 1.15 (0.96–1.37) 0.13 1.10 (0.99–1.23) 1.09 (0.97–1.22) 0.14
Odds ratio >1 indicate higher utilization in individuals using CM; odds ratio <1 indicates higher utilization in individuals not using CM. Adjusted odds ratio 
and P- values were derived from logistic regression analyses controlling for age, sex, education, employment, marital status, region of origin, race/ethnicity, 
health insurance coverage, noncardiovascular comorbidities, CVD risk factors, and CVD type (CVD patients only). Relative weights were used. CM indicates 
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medicine, defined as supplement use and consulta-
tions with complementary healthcare practitioners, 
within the past 12 months. Complementary healthcare 
users had a significantly higher number of general or 
specified medical practitioner consultations than non-
users.27 Analogous retrospective data among patients 
with  diabetes mellitus treated in the Bastyr Center for 
Natural Health were analyzed and published in 2006. 
The analysis showed that naturopathic and conven-
tional care were typically jointly used.28
Other studies also showed a general connection 
between the utilization of complementary and conven-
tional healthcare utilization in other patient populations. 
According to Reid et  al,29 complementary medicine 
users in Australia tend to use conventional medical care 
more often. Although there are many reasons for use of 
complementary medicine, chronic illnesses are a major 
reason according to data from Australia, Canada, and 
the United States.29–31 Chronic illnesses treated with 
complementary medicine include chronic pain, depres-
sion, and CVD,13 although only 10% of patients used 
complementary approaches for direct treatment of their 
CVD.32 Some data suggest that CVD patients utilizing 
complementary methods suffer from poorer health 
conditions33 and a lower quality of life29 when com-
pared with nonusers. A poorer health condition may 
derive from a higher rate of chronic comorbidities such 
as anxiety, pain disorders, insomnia, or others,26,27 and 
not the CVD itself. Predictive factors for complemen-
tary healthcare utilization in general and specifically in 
CVDs are female sex, middle- age, higher educational 
level and income,13,27,34 and greater health literacy.35 
Because health literacy is also associated with a higher 
utilization of conventional health care, it may be relevant 
for the positive association between conventional and 
complementary healthcare utilization.36,37 Future stud-
ies could further target this association.
There are limitations to our findings. The NHIS sur-
vey is an annual cross- sectional survey. Although our 
analysis showed a positive relationship between use 
of complementary and conventional health care, there 
is no evidence for a causal relationship between the 2 
types of healthcare use. In addition, the survey con-
tains self- reported data from noninstitutionalized US 
citizens. As diagnoses and healthcare utilization could 
not be cross- validated from medical records, respon-
dents may tend to answer in a way that makes a good 
impression on the researcher. Respondents may also 
show misclassification or recall bias. Also, in the 2012 
NHIS, there were no queries about reasons for con-
sulting a specific practitioner. Thus, we could not as-
sess the exact reason for healthcare utilization. In 2017, 
the NHIS only assessed a limited number of comple-
mentary therapies. Commonly used approaches, such 
as consultations with acupuncturists or use of sup-
plements, were not assessed. Likewise, only a limited 
number of noncardiovascular comorbidities could be 
included in the analyses.
In individuals with CVD or CVD risk factors, com-
plementary healthcare utilization is highly prevalent, 
as shown in our results. It also seems that individuals 
utilizing complementary health care also tend to con-
sult more frequently with general medical practitioners. 
Referring to the American Heart Association guide-
lines, studies showed that team- based treatment for 
patients improves the benefit and outcome of lifestyle 
change in patients with CVD. In addition to receiving 
support from the family, this also includes seeking 
care from different healthcare professions.8 Although 
the American Heart Association guideline addresses 
consultation with general clinical institutions, our data 
show that complementary care may be supportive as 
well. Further investigation will be needed.
CONCLUSIONS
Both conventional and complementary health care are 
used commonly among individuals with or at risk for 
CVD. Individuals with CVD or CVD risk factors con-
sulting complementary medicine practitioners and/or 
using MBM more likely consult general medical prac-
titioners as well. In manifest CVDs, significantly more 
patients tend to consult medical specialists when 
using complementary medicine than nonusers. More 
individuals using complementary medicine also tend 
to adhere to recommended checkups. Thus, our data 
are not compatible with a hypothesized negative as-
sociation of complementary healthcare utilization and 
nonadherence to conventional therapy and diagnos-
tics in individuals with or at risk for CVD. The potential 
positive association of complementary and conven-
tional utilization of health care needs to be confirmed 
in further studies.
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